The MassDevice Weekly Checkup: June 15, 2010
June 14, 2010 by Anonymous
Taking the financial temperature of the medical devices industry.
Our Weekly Checkup takes the temperature of the medical device industry's three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of shares outstanding for each company and each Friday's closing share price.
The Massachusetts index for the week ended June 11 closed at 5.78, up 0.6 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 30.6 percent.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
Navigation
NEWS
European regulators green-light valve-in-valve procedures
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
Biosense Webster launches Afib ablation study for nMARQ system
Johnson & Johnson subsidiary Biosense Webster enrolls its 1st patient in the reMARQable clinical...
GPO: Healthcare collaborative teams up within the Premier network
Four health systems create a collaborative group as part of the Premier network
Agea Medical has its sights on an $8 million offering
Agea Medical is $2 million shy of its $8 million funding round goal
FDA panel to consider down-classifying blade-form dental implants
The FDA's Dental Products Panel is scheduled to deliberate on whether the agency should lower blade-...
